Bio-Rad Laboratories BIO
NYSE BIO
$375.67 -6.74 (-1.76%)
As of: Sep 18, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Gross Profit Growth (3y) (2012 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 4.04%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 2.86%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 16.56%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 1.70%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 1.19%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 1.08%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -1.56%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 11.28%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 4.14%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 6.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.56%
Mar 31, 2026 -5.13%
Dec 31, 2025 -4.56%
Sep 30, 2025 -2.68%
Jun 30, 2025 -4.38%
Mar 31, 2025 -8.74%
Dec 31, 2024 -5.08%
Sep 30, 2024 -6.58%
Jun 30, 2024 -3.98%
Mar 31, 2024 -6.64%
Dec 31, 2023 -7.32%
Sep 30, 2023 -2.95%
Jun 30, 2023 7.35%
Mar 31, 2023 4.52%
Dec 31, 2022 6.32%
Sep 30, 2022 6.67%
Jun 30, 2022 8.67%
Mar 31, 2022 8.89%
Dec 31, 2021 6.34%
Sep 30, 2021 15.04%